Effects of Aromatherapy After Aerobic Exercise"

July 18, 2025 updated by: Bezmialem Vakif University

The Effect of Aromatherapy Application on Recovery Speed and Cardiovascular Parameters After Aerobic Exercise in Athletes

This study aims to investigate the effect of aromatherapy using lavender oil on recovery speed and cardiovascular parameters in healthy athletes following aerobic exercise. Participants will perform aerobic exercise using the Bruce treadmill protocol and will be randomly assigned to either an aromatherapy group (inhaling lavender essential oil) or a control group (no aromatherapy). Heart rate, blood pressure, oxygen saturation, perceived exertion, and fatigue levels will be measured before and after exercise. The study seeks to determine whether aromatherapy contributes to faster physiological recovery and reduced fatigue following exercise.

Study Overview

Detailed Description

Aromatherapy has gained popularity as a complementary approach in sports science, with claims of improving relaxation, reducing fatigue, and enhancing recovery. Lavender essential oil, in particular, has been associated with cardiovascular modulation and reduced perception of exertion. However, its efficacy in post-exercise recovery among athletes remains under-investigated.

This randomized controlled trial will evaluate the physiological and perceptual effects of lavender aromatherapy in athletes following aerobic exertion. Participants aged 15-35 with at least 6 months of regular sports participation will be included. The intervention group will receive inhalation-based lavender oil aromatherapy for 5 minutes after completing the Bruce treadmill protocol, while the control group will rest without aromatherapy.

Primary and secondary outcomes include heart rate recovery, blood pressure, oxygen saturation (SpO₂), Borg RPE score, and fatigue severity. Data will be collected at baseline, immediately after exercise, and at 5-minute intervals during recovery. The findings are expected to provide insights into the use of non-pharmacological recovery strategies in athletic populations.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Bezmialem Vakif University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Aged between 12 and 14 years

Actively engaged in organized sports training (minimum 2 times per week)

Medically cleared to participate in moderate to vigorous physical activity

No known cardiovascular, respiratory, neurological, or metabolic conditions

Provided informed assent and obtained written parental/guardian consent

Exclusion Criteria:

Known allergy to lavender or any component of aromatherapy oils

Use of medications that may alter cardiovascular responses (e.g., beta-blockers)

History of cardiac disease, hypertension, or arrhythmia

Acute or recent musculoskeletal injury (within the last 3 months)

Acute upper respiratory tract infection during the assessment week

Inability to complete treadmill exercise testing or follow instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aromatherapy Group
Participants in this group performed aerobic exercise using the Bruce treadmill protocol. After completing the exercise, they were taken to a separate room where a diffuser had been running for 15 minutes, containing 3 drops of lavender essential oil in 100 ml of water. They inhaled the aromatherapy during a 15-minute recovery period while cardiovascular parameters were monitored.
Participants inhaled lavender essential oil (3 drops in 100 ml water) via diffuser during a 15-minute post-exercise recovery period following the Bruce treadmill protocol.
Placebo Comparator: Placebo Group
Participants in this group performed aerobic exercise using the Bruce treadmill protocol. After exercise, they were taken to a separate room where a diffuser had been operating for 15 minutes with only 100 ml of plain water and no essential oils. They rested in this environment for 15 minutes, during which their cardiovascular parameters were monitored. This arm aimed to control for the effect of the diffuser itself without the therapeutic component of lavender oil.
Participants were exposed to plain water vapor (100 ml of water without essential oil) via diffuser for 15 minutes during post-exercise recovery.
No Intervention: Control Group
Participants in this group performed aerobic exercise using the Bruce treadmill protocol. After the exercise, they rested in a standard environment without exposure to any diffuser or aromatherapy. Their cardiovascular parameters were monitored during a 15-minute recovery period, serving as the baseline comparison for evaluating the effects of aromatherapy and placebo.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate Recovery
Time Frame: Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery
Heart rate was measured using a fingertip pulse oximeter. Participants remained seated and still during the measurements to ensure accuracy. The device provided real-time heart rate readings, recorded manually by the researcher.
Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery
Systolic and Diastolic Blood Pressure
Time Frame: Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery
Blood pressure was measured with a calibrated manual sphygmomanometer and a standard stethoscope using the auscultatory method. All measurements were taken from the left arm, with the participant in a seated position, after at least one minute of rest.
Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen Saturation (SpO₂)
Time Frame: Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery
Oxygen saturation was assessed using a non-invasive fingertip pulse oximeter. The sensor was placed on the index finger of the dominant hand, and values were recorded once a stable reading was obtained.
Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery
Rating of Perceived Exertion
Time Frame: Immediately post-exercise and after 15 minutes of recovery
Participants were asked to rate their level of exertion using the Borg 6-20 scale. The scale was visually presented, and participants pointed to the value that best represented their perceived effort. This method is validated and widely used in exercise science.
Immediately post-exercise and after 15 minutes of recovery
Fatigue Severity Score
Time Frame: Before exercise and after 15 minutes of recovery
The FSS questionnaire was administered in printed form. Participants completed the 9-item scale independently in a quiet environment. Each item was scored on a 7-point Likert scale, and the total score was calculated by averaging all responses.
Before exercise and after 15 minutes of recovery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2024

Primary Completion (Actual)

October 16, 2024

Study Completion (Actual)

November 10, 2024

Study Registration Dates

First Submitted

July 18, 2025

First Submitted That Met QC Criteria

July 18, 2025

First Posted (Actual)

July 25, 2025

Study Record Updates

Last Update Posted (Actual)

July 25, 2025

Last Update Submitted That Met QC Criteria

July 18, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to ethical considerations related to the age group of participants (12-14 years), the sensitivity of health-related information collected, and the limited scope of the study. The study involves minors, and although parental consent and participant assent were obtained, data sharing beyond the primary research team was not included in the consent process. Therefore, data will remain confidential and used solely for the purposes outlined in the approved study protocol.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Performance

Clinical Trials on Aromatherapy

Subscribe